The Prevalence and Prognostic Value of BRAFV600E Mutation in Papillary Thyroid Cancer

International Journal of Human and Health Sciences (IJHHS)
doi 10.31344/ijhhs.v3i4.106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Journal of Human and Health Sciences IJHHS

Related search

BRAFV600E Mutation and Papillary Thyroid Cancer—In Reply

JAMA - Journal of the American Medical Association
Medicine
2013English

Clinical Implication of the BRAFV600E Mutation in Papillary Thyroid Carcinoma

World Journal of Surgical Oncology
SurgeryOncology
2013English

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Vemurafenib for BRAFV600E-positive Metastatic Papillary Thyroid Cancer – Authors' Response

The Lancet Oncology
Oncology
2016English

IL-12 Immunotherapy of BrafV600E-induced Papillary Thyroid Cancer in a Mouse Model

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

The Value of Preoperative PET–CT in Papillary Thyroid Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2013English

Prognostic Importance of Immunologochemical Markers of Papillary Thyroid Cancer

ScienceRise: Medical Science
2019English

Table 4: Diagnostic Value of circRNAs in Papillary Thyroid Cancer.

English

Diagnostic Value of BRAFV600E-mutation Analysis in Fine-Needle Aspiration of Thyroid Nodules: A meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy